Surfactant administration during endotracheal CPAP-Is DD-Surf comparable to LISA?
- PMID: 37163241
- DOI: 10.1111/apa.16834
Surfactant administration during endotracheal CPAP-Is DD-Surf comparable to LISA?
Comment in
-
Author's response to 'Surfactant administration during endotracheal CPAP-Is DD-SURF comparable to LISA?'.Acta Paediatr. 2023 Aug;112(8):1810-1811. doi: 10.1111/apa.16840. Epub 2023 May 19. Acta Paediatr. 2023. PMID: 37166439 No abstract available.
Comment on
-
Surfactant administration during endotracheal CPAP: Feasibility, risk factors for failure and short-term outcomes of DD-SURF.Acta Paediatr. 2023 Aug;112(8):1653-1658. doi: 10.1111/apa.16767. Epub 2023 Mar 30. Acta Paediatr. 2023. PMID: 36946356
References
REFERENCES
-
- Yeung TY, Zhou Q, Kanmaz Kutman HG, Pandita A, Philippopoulos E, Jasani B. Surfactant delivery via thin catheter in preterm infants: a systematic review and meta-analysis. PLoS One. 2023;18(4):e0284792.
-
- Mense L, Hansmann T, Seipolt B, Kaufmann M, Rudiger M. Surfactant administration during endotracheal CPAP: feasibility, risk factors for failure and short-term outcomes of DD-SURF. Acta Paediatr. 2023;112(8):1653-1658. doi:10.1111/apa.16767
-
- Sweet DG, Carnielli VP, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome: 2022 update. Neonatology. 2023;120(1):3-23.
-
- Gynecology TACoOa. The Apgar Score. 2015. Accessed March 04, 2023. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articl...
-
- Balazs G, Balajthy A, Riszter M, et al. Incidence, predictors of success and outcome of LISA in very preterm infants. Pediatr Pulmonol. 2022;57(7):1751-1759.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources